PGI Chandigarh Union seeks high-level probe into Ayushman Bharat fraud

Published On 2025-04-24 11:27 GMT   |   Update On 2025-04-24 11:27 GMT
Advertisement

Nearly a month after a youth fraudulently claimed Rs 60k worth of medicines under the Ayushman Bharat- PMJAY scheme using forged documents and fake stamps from the pharmacy of the Postgraduate Institute of Medical Education and Research (PGIMER) Chandigarh, the joint action committee of the institute's Contract Workers’ Union has urged the central government to constitute a high level panel to probe the employees role in connection to the case.

In a letter to the Union Ministry of Health and Family Welfare, the committee asked the government to set up a special committee to investigate possible irregularities in the Ayushman scheme. The union's joint action committee claimed that some employees from the medical superintendent’s office and the private grant cell may be involved in the alleged scam.

For more information, click on the link below:

Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News